Given such close association of CD146 with PAH features and the broad impact of CD146 in vascular disorders, we aimed to determine the connection between CD146 and HIF-1α in vascular remodeling, and to further explore its potential as an anti-remodeling target for PAH therapy. Here, HIF1A is linked to pulmonary arterial hypertension.